TY - JOUR
T1 - An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo
AU - Galassi, Thomas V.
AU - Jena, Prakrit V.
AU - Shah, Janki
AU - Ao, Geyou
AU - Molitor, Elizabeth
AU - Bram, Yaron
AU - Frankel, Angela
AU - Park, Jiwoon
AU - Jessurun, Jose
AU - Ory, Daniel S.
AU - Haimovitz-Friedman, Adriana
AU - Roxbury, Daniel
AU - Mittal, Jeetain
AU - Zheng, Ming
AU - Schwartz, Robert E.
AU - Heller, Daniel A.
N1 - Publisher Copyright:
Copyright © 2018 The Authors, some rights reserved.
PY - 2018/10/3
Y1 - 2018/10/3
N2 - The abnormal accumulation of lipids within the endolysosomal lumen occurs in many conditions, including lysosomal storage disorders, atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and drug-induced phospholipidosis. Current methods cannot monitor endolysosomal lipid content in vivo, hindering preclinical drug development and research into the mechanisms linking endolysosomal lipid accumulation to disease progression. We developed a single-walled carbon nanotube–based optical reporter that noninvasively measures endolysosomal lipid accumulation via bandgap modulation of its intrinsic near-infrared emission. The reporter detected lipid accumulation in Niemann-Pick disease, atherosclerosis, and NAFLD models in vivo. By applying the reporter to the study of NAFLD, we found that elevated lipid quantities in hepatic macrophages caused by a high-fat diet persist long after reverting to a normal diet. The reporter dynamically monitored endolysosomal lipid accumulation in vivo over time scales ranging from minutes to weeks, indicating its potential to accelerate preclinical research and drug development processes.
AB - The abnormal accumulation of lipids within the endolysosomal lumen occurs in many conditions, including lysosomal storage disorders, atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and drug-induced phospholipidosis. Current methods cannot monitor endolysosomal lipid content in vivo, hindering preclinical drug development and research into the mechanisms linking endolysosomal lipid accumulation to disease progression. We developed a single-walled carbon nanotube–based optical reporter that noninvasively measures endolysosomal lipid accumulation via bandgap modulation of its intrinsic near-infrared emission. The reporter detected lipid accumulation in Niemann-Pick disease, atherosclerosis, and NAFLD models in vivo. By applying the reporter to the study of NAFLD, we found that elevated lipid quantities in hepatic macrophages caused by a high-fat diet persist long after reverting to a normal diet. The reporter dynamically monitored endolysosomal lipid accumulation in vivo over time scales ranging from minutes to weeks, indicating its potential to accelerate preclinical research and drug development processes.
UR - http://www.scopus.com/inward/record.url?scp=85054454387&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aar2680
DO - 10.1126/scitranslmed.aar2680
M3 - Article
C2 - 30282694
AN - SCOPUS:85054454387
SN - 1946-6234
VL - 10
JO - Science translational medicine
JF - Science translational medicine
IS - 461
M1 - eaar2680
ER -